Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (11): 23-27.doi: 10.6040/j.issn.1671-7554.0.2022.0978

• Special Issue in Minimally Invasive Surgery and Enhanced Recovery After Surgery in Lung Cancer and Esophageal Cancer • Previous Articles     Next Articles

Minimally invasive sleeve lobectomy: opportunities and challenges in the era of immunotherapy

Huijiang GAO,Yucheng WEI*()   

  1. Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China
  • Received:2022-08-18 Online:2022-11-01 Published:2022-11-04
  • Contact: Yucheng WEI E-mail:weiyuchengchest@163.com

RichHTML

0

PDF (PC)

14

Abstract:

Sleeve lobectomy, as a standard treatment for locally advanced resectable central lung cancer, can maximize the preservation of lung tissue and improve patients' quality of life without affecting survival, compared with total pneumonectomy. With the development of thoracoscopic and robotic technology, minimally invasive sleeve lobectomy has become a routine procedure in thoracic surgery, although bronchial sleeve lobectomy has increased the difficulty of operation. At present, with the development of immunotherapy in the field of neoadjuvant and induction therapy for lung cancer, a growing number of locally advanced resectable or potentially resectable lung cancer has been treated with immunotherapy. This not only improves the prognosis of patients, but also puts forward higher requirements for minimally invasive thoracic surgery, especially minimally invasive sleeve lobectomy. In this paper, the current situation of minimally invasive sleeve lobectomy is systematically described and the prospect is prospected.

Key words: Centrally-located lung cancer, Minimally invasive, Sleeve lobectomy, Immunotherapy, Survival

CLC Number: 

  • R734.2
1 Siegel RL , Miller KD , Fuchs HE , et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72 (1): 7- 33.
doi: 10.3322/caac.21708
2 Xia C , Dong X , Li H , et al. Cancer statistics in china and united states, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135 (5): 584- 590.
doi: 10.1097/CM9.0000000000002108
3 Paulson DL , Shaw RR . Preservation of lung tissue by means of bronchoplastic procedures[J]. Am J Surg, 1955, 89 (2): 347- 355.
doi: 10.1016/0002-9610(55)90074-X
4 Tedder M , Anstadt MP , Tedder SD , et al. Current morbidity, mortality, and survival after bronchoplastic procedures for malignancy[J]. Ann Thorac Surg, 1992, 54 (2): 387- 391.
doi: 10.1016/0003-4975(92)91413-4
5 Abdelsattar ZM , Shen KR , Yendamuri S , et al. Outcomes after sleeve lung resections versus pneumonectomy in the united states[J]. Ann Thorac Surg, 2017, 104 (5): 1656- 1664.
doi: 10.1016/j.athoracsur.2017.05.086
6 Li Z , Chen W , Xia M , et al. Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis[J]. Transl Lung Cancer Res, 2019, 8 (6): 775- 786.
doi: 10.21037/tlcr.2019.10.11
7 Merritt RE , Mathisen DJ , Wain JC , et al. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms[J]. Ann Thorac Surg, 2009, 88 (5): 1574- 1581.
doi: 10.1016/j.athoracsur.2009.07.060
8 Ludwig C , Stoelben E , Olschewski M , et al. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma[J]. Ann Thorac Surg, 2005, 79 (3): 968- 973.
doi: 10.1016/j.athoracsur.2004.08.062
9 Kwon ST , Zhao L , Reddy RM , et al. Evaluation of acute and chronic pain outcomes after robotic, video-assisted thoracoscopic surgery, or open anatomic pulmonary resection[J]. J Thorac Cardiovasc Surg, 2017, 154 (2): 652- 659.
doi: 10.1016/j.jtcvs.2017.02.008
10 Bendixen M , Jorgensen OD , Kronborg C , et al. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial[J]. Lancet Oncol, 2016, 17 (6): 836- 844.
doi: 10.1016/S1470-2045(16)00173-X
11 Yang HX , Woo KM , Sima CS , et al. Long-term survival based on the surgical approach to lobectomy for clinical stage Ⅰ nonsmall cell lung cancer: comparison of robotic, video-assisted thoracic surgery, and thoracotomy lobectomy[J]. Ann Surg, 2017, 265 (2): 431- 437.
doi: 10.1097/SLA.0000000000001708
12 潘茂杰, 高会江, 蒋志慧, 等. 基于倾向性评分匹配法的胸腔镜与开放袖式肺叶切除术近期与远期疗效比较[J]. 中华外科杂志, 2018, 56 (7): 533- 537.
13 Gao HJ , Jiang ZH , Gong L , et al. Video-assisted vs thoracotomy sleeve lobectomy for lung cancer: a propensity matched analysis[J]. Ann Thorac Surg, 2019, 108 (4): 1072- 1079.
doi: 10.1016/j.athoracsur.2019.04.037
14 Zhang C , Ma Y , Yu Z , et al. Comparison of efficacy and safety of hybrid video-assisted thoracoscopic surgery vs. thoracotomy sleeve lobectomy for non-small cell lung cancer: a propensity score matching study[J]. J Thorac Dis, 2022, 14 (7): 2635- 2644.
doi: 10.21037/jtd-22-754
15 Yang Y , Mei J , Lin F , et al. Comparison of the short- and long-term outcomes of video-assisted thoracoscopic surgery versus open thoracotomy bronchial sleeve lobectomy for central lung cancer: a retrospective propensity score matched cohort study[J]. Ann Surg Oncol, 2020, 27 (11): 4384- 4393.
doi: 10.1245/s10434-020-08805-y
16 Xie D , Deng J , Gonzalez-Rivas D , et al. Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2021, 161 (2): 403- 413.e2.
doi: 10.1016/j.jtcvs.2020.01.105
17 Ettinger DS , Wood DE , Aisner DL , et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20 (5): 497- 530.
doi: 10.6004/jnccn.2022.0025
18 Provencio M , Serna-Blasco R , Nadal E , et al. Overall survival and biomarker analysis of neoadjuvant nivolumab plus chemotherapy in operable stage ⅢA non-small-cell lung cancer (NADIM phase Ⅱ trial)[J]. J Clin Oncol, 2022, 40 (25): 2924- 2933.
doi: 10.1200/JCO.21.02660
19 Sierra-Rodero B , Cruz-Bermudez A , Nadal E , et al. Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial[J]. J Immunother Cancer, 2021, 9 (8): e002804.
doi: 10.1136/jitc-2021-002804
20 Provencio M , Nadal E , Insa A , et al. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial[J]. Lancet Oncol, 2020, 21 (11): 1413- 1422.
doi: 10.1016/S1470-2045(20)30453-8
21 Forde PM , Spicer J , Lu S , et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer[J]. N Engl J Med, 2022, 386 (21): 1973- 1985.
doi: 10.1056/NEJMoa2202170
22 Deng H , Liu J , Cai X , et al. Radical minimally invasive surgery after immuno-chemotherapy in initially-unresectable stage ⅢB non-small cell lung cancer[J]. Ann Surg, 2022, 275 (3): e600- e602.
doi: 10.1097/SLA.0000000000005233
23 Liang H , Yang C , Gonzalez-Rivas D , et al. Sleeve lobectomy after neoadjuvant chemoimmunotherapy/chemotherapy for local advanced non-small cell lung cancer[J]. Transl Lung Cancer Res, 2021, 10 (1): 143- 155.
doi: 10.21037/tlcr-20-778
24 Petersen RH , Hansen HJ . Learning curve associated with VATS lobectomy[J]. Ann Cardiothorac Surg, 2012, 1 (1): 47- 50.
25 Rendina EA , Venuta F , Ricci P , et al. Protection and revascularization of bronchial anastomoses by the intercostal pedicle flap[J]. J Thorac Cardiovasc Surg, 1994, 107 (5): 1251- 1254.
doi: 10.1016/S0022-5223(94)70045-1
26 Storelli E , Tutic M , Kestenholz P , et al. Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy[J]. Eur J Cardiothorac Surg, 2012, 42 (1): 77- 81.
doi: 10.1093/ejcts/ezr291
27 Lewis RJ , Caccavale RJ , Sisler GE , et al. One hundred consecutive patients undergoing video-assisted thoracic operations[J]. Ann Thorac Surg, 1992, 54 (3): 421- 426.
doi: 10.1016/0003-4975(92)90431-3
28 Santambrogio L , Cioffi U , De Simone M , et al. Video-assisted sleeve lobectomy for mucoepidermoid carcinoma of the left lower lobar bronchus: a case report[J]. Chest, 2002, 121 (2): 635- 636.
doi: 10.1378/chest.121.2.635
29 Mahtabifard A , Fuller CB , McKenna RJ Jr . Video-assisted thoracic surgery sleeve lobectomy: a case series[J]. Ann Thorac Surg, 2008, 85 (2): S729- 732.
doi: 10.1016/j.athoracsur.2007.12.001
30 Schmid T , Augustin F , Kainz G , et al. Hybrid video-assisted thoracic surgery-robotic minimally invasive right upper lobe sleeve lobectomy[J]. Ann Thorac Surg, 2011, 91 (6): 1961- 1965.
doi: 10.1016/j.athoracsur.2010.08.079
31 Gu C , Pan X , Chen Y , et al. Short-term and mid-term survival in bronchial sleeve resection by robotic system versus thoracotomy for centrally located lung cancer[J]. Eur J Cardiothorac Surg, 2018, 53 (3): 648- 655.
doi: 10.1093/ejcts/ezx355
32 Gonzalez-Rivas D , Fernandez R , Fieira E , et al. Uniportal video-assisted thoracoscopic bronchial sleeve lobectomy: first report[J]. J Thorac Cardiovasc Surg, 2013, 145 (6): 1676- 1677.
doi: 10.1016/j.jtcvs.2013.02.052
33 Gonzalez-Rivas D , Yang Y , Stupnik T , et al. Uniportal video-assisted thoracoscopic bronchovascular, tracheal and carinal sleeve resections[J]. Eur J Cardiothorac Surg, 2016, 49 (Suppl 1): i6- 16.
34 Cerfolio RJ . Robotic sleeve lobectomy: technical details and early results[J]. J Thorac Dis, 2016, 8 (Suppl 2): 223- 226.
35 Pan X , Gu C , Wang R , et al. Initial experience of robotic sleeve resection for lung cancer patients[J]. Ann Thorac Surg, 2016, 102 (6): 1892- 1897.
doi: 10.1016/j.athoracsur.2016.06.054
36 Zhong Y , Wang Y , Hu X , et al. A systematic review and meta-analysis of thoracoscopic versus thoracotomy sleeve lobectomy[J]. J Thorac Dis, 2020, 12 (10): 5678- 5690.
doi: 10.21037/jtd-20-1855
37 No authors listed . Neoadjuvant PD-1 blockade in resectable lung cancer; nivolumab and ipilimumab in advanced melanoma; overall survival with combined nivolumab and ipilimumab in advanced melanoma; prolonged survival in stage Ⅲ melanoma with ipilimumab adjuvant therapy; combined nivolumab and ipilimumab or monotherapy in untreated melanoma; combined nivolumab and ipilimumab or monotherapy in untreated melanoma; nivolumab and ipilimumab versus ipilimumab in untreated melanoma; rapid eradication of a bulky melanoma mass with one dose of immunotherapy; genetic basis for clinical response to ctla-4 blockade; genetic basis for clinical response to CTLA-4 blockade in melanoma; nivolumab plus ipilimumab in advanced melanoma; safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma; hepatotoxicity with combination of vemurafenib and ipilimumab[J]. N Engl J Med, 2018, 379 (22): 2185.
doi: 10.1056/NEJMx180040
38 Kim HK , Cho JH , Choi YS , et al. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease[J]. Lung Cancer, 2016, 96, 56- 62.
doi: 10.1016/j.lungcan.2016.03.016
39 Rendina EA , Venuta F , De Giacomo T , et al. Safety and efficacy of bronchovascular reconstruction after induction chemotherapy for lung cancer[J]. J Thorac Cardiovasc Surg, 1997, 114 (5): 830- 835.
doi: 10.1016/S0022-5223(97)70088-6
40 Chriqui LE , Forster C , Lovis A , et al. Is sleeve lobectomy safe after induction therapy a systematic review and meta-analysis[J]. J Thorac Dis, 2021, 13 (10): 5887- 5898.
doi: 10.21037/jtd-21-939
[1] GAO Zhongxia, ZHANG Ming, FAN Mingde, TAN Chenyang, WANG Mengdi, WANG Chao, FAN Yuefei, DING Shouluan, WANG Chengwei. Efficacy and prognostic factors of gamma knife in treating 81 cases of brain metastases from lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 44-49.
[2] QIN Jing, YANG Fei, CHEN Qian, XIA Handai, LIU Yanguo, WANG Xiuwen. A network meta-analysis of first-line treatment options for patients with advanced driver-gene wild-type and PD-L1 negative non-squamous non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 74-82.
[3] KONG Linxiaoyu, SUN Shuzhen, YU Lichun, JIA Mengwen. Analysis of 5-year survival rate and prognosis in 188 children with systemic lupus erythematosus [J]. Journal of Shandong University (Health Sciences), 2022, 60(12): 69-76.
[4] Guowei CHE. It is necessary for enhanced recovery after surgery to keep pace with the times [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 17-22.
[5] SUN Zhenguo, TIAN Hui. Optimization of the procedures in minimally invasive esophagectomy: the Qilu practices [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 33-37.
[6] LI Mingbo, HUANG Yanbo, REN Dongcheng, LIU Juncheng, TAN Chengshuang, XU Jixi, DING Jinyong. Afinite element analysis of three different fusion methods of lumbar internal fixation [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 55-64.
[7] TIAN Hui, LI Shuhai, LI Lin, QI Lei, LU Ming, CHENG Chuanle. Quality control of minimally invasive esophagectomy in Qilu Hospital [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 78-82.
[8] YU Jinming, YAN Weiwei, CHEN Dawei. New practice of radio-immunotherapy for lung cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 1-8.
[9] MAO Qian, WANG Zhe, GUAN Peixia, LIU Yujie, XIAO Yufei, YANG Yi, CONG Huiwen,WANG Lianyuan, SHI Fuyan, WANG Suzhen. Correlation analysis of dynamic changes of uric acid and incidence of gout in 1,144 cases [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 107-112.
[10] DENG Xiaohui, GUO Ling. Applications and progress of immunotherapy in repeated implantation failure [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 32-37.
[11] SUN Qingjie, ZHANG Yisha, GUAN Shanghui, FENG Zhihui. Effects of valproic acid on the survival and tumor recurrence of 134 patients with glioma treated with radiotherapy [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 80-85.
[12] XIE Tonghui, CHEN Zhiqiang, CHANG Jianhua, ZHAO Danwen, XU Bowen, ZHI Xuting. Analysis of prognostic factors after radical resection of intrahepatic cholangiocarcinoma and establishment of a nomogram [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 93-99.
[13] PANG Zhaofei, LIU Yong, ZHAO Xiaogang, YAN Tao, CHEN Xiaowei, DU Jiajun. Construction of a stemness-based scoring model predicting the efficacy of immunotherapy in lung adenocarcinoma based on public databases [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 19-28.
[14] CHAI Xiaoxue, YE Hui, LYU Xinran, DING Xuchao, ZHEN Qiulai, DU Juan, CAO Lili. Prognostic value of POU4F3 in 118 patients with lung adenocarcinoma and its effect on migration of lung adenocarcinoma cells [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 8-18.
[15] ZHEN Qiulai, LYU Xinran, YE Hui, DING Xuchao, CHAI Xiaoxue, HU Xin, ZHOU Ming, CAO Lili. Predicting colon cancer prognosis genes and clinical application value based on TCGA database [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 64-71.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] ZHENG Min,HAO Yue-wei,LIU Xue-ping,ZHAO Ting-ting. Relationship between the HPA-2 and Kozak sequence polymorphism of platelet membrane glycoprotein and cerebral infarction[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(3): 292 -295 .
[2] ZHANG Jie,LI Zhen-hua,SUN Jin-hao,BAO Li-hua,LIU Yue-peng. Protective effects of the invariable magnetic field on oxidative injured Schwann cells[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(3): 229 -232 .
[3] WU Min,ZHAO Zhi-lun,WANG Jie-zhen. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(11): 1146 -1149 .
[4] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(03): 106 -108 .
[5] YU Shuping1， MA Chunhu2， WANG Yukun1
. Expressions of programmed cell death 4 and
Ki67 in granuloma fungoides[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(04): 104 .
[6] JIAO Fang-fang,LIU Shi-qing,LI Fei,LI Chang-sheng,WANG Qin,SUN Qing,LU Wei. Therapeutic effects of Huayulifei on expression of SMAD7 and TGF-β in rats with bleomycin-induced pulmonary fibrosis[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(10): 1054 -1058 .
[7] ZHAO Ying， YAN Lei， ZHANG Hui， YU Peng， LI Ming-jiang， ZHAO Xing-bo. Expression of SPAG9 in patients with serous epithelial ovarian tumors[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 98 .
[8] DAI Jun1, LIU Pei-shu1， MA Dao-xin2, CHANG Xin-zhong1, FENG Jin-bo1, YIN Ge-ping3. Expressions of cyclinD1 in ovarian cancer transplanted into nude mice[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(6): 57 -60 .
[9] ZHANG Wen-hua, XU Shu-jun, JIANG Yu-quan, LI Gang, LI Xin-gang, ZHOU Mao-de, WU Cheng-yuan. Protective effect of tricyclic antidepressant nortryptyline of cortical  neurons on rats with OGD-induced injury and its mechanism[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 29 -32 .
[10] WANG Bo-song, ZHONG Jing-quan, LI Jing-sha, ZENG Qi-xian, LIU Hong-zhen, SU Guo-ying, LIU Dong-lin， ZHANG Yun. Comparison of effects of continuous and one-shock defibrillations on a  canine model of prolonged ventricular fibrillation[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 37 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd